Platelet TGF-β1 inhibits the migration and proliferation of smooth muscle cells in aneurysms

Xiaowei Liu1, Cheng Xu2, Jiangjie Lou1

  • 1Department of Cardiology, Zhejiang Hospital, China.

Cytokine
|August 5, 2022
PubMed
Abstract

Insights

Platelet transforming growth factor-beta 1 (TGF-β1) inhibits angiotensin II (Ang II)-induced vascular smooth muscle cell dysfunction. This finding offers potential therapeutic insights for aortic injury by demonstrating TGF-β1

Area of Science:

  • Cardiovascular Biology
  • Vascular Cell Biology
  • Platelet Physiology

Background:

  • Excessive proliferation, migration, and invasion of murine aortic vascular smooth muscle cells (MASMCs) contribute to vascular disease.
  • Platelet-derived growth factors play a critical role in regulating vascular cell behavior.
  • Understanding the specific roles of platelet components, like TGF-β1, is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the inhibitory role of platelet-derived transforming growth factor-beta 1 (TGF-β1) on angiotensin II (Ang II)-induced MASMC dysfunction.
  • To explore the therapeutic potential of TGF-β1 in mitigating Ang II-induced vascular injury in vivo.
  • To elucidate the molecular mechanisms underlying TGF-β1's effects on MASMCs.

Main Methods:

  • MASMCs were treated with varying concentrations of Ang II and TGF-β1 to determine optimal intervention levels.
  • In vitro experiments assessed the effects of platelets, Ang II, and TGF-β1 on MASMC proliferation, migration, and invasion using cell-based assays and Western blotting.
  • An in vivo Ang II-induced mouse model was used to evaluate the therapeutic efficacy of TGF-β1, with mechanistic insights gained from inhibitor studies and pathological analysis.

Main Results:

  • Ang II significantly promoted MASMC proliferation, migration, and invasion by modulating related signaling pathways.
  • Exogenous TGF-β1 and platelet treatment effectively reversed the pro-proliferative, migratory, and invasive effects of Ang II on MASMCs.
  • In vivo, TGF-β1 administration demonstrated a protective effect against Ang II-induced abdominal aortic injury in mice, consistent with in vitro findings.

Conclusions:

  • Platelet-derived TGF-β1 acts as a key inhibitor of Ang II-induced MASMC proliferation, migration, and invasion.
  • TGF-β1 holds therapeutic promise for treating vascular pathologies driven by Ang II signaling.
  • The study highlights the critical role of platelet components in vascular homeostasis and disease modulation.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
68
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.8K
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker...
4.8K